Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
devimistat (2 trials)
docetaxel (taxotere) (1 trial)
estramustine (emcyt) (1 trial)
gemcitabine (gemzar) (1 trial)
thalidomide (Thalomid) (1 trial)
fulvestrant (faslodex) (1 trial)
gedatolisib (1 trial)
goserelin (zoladex) (1 trial)
palbociclib (ibrance) (1 trial)
Breast Neoplasms (Phase 1)
Carcinoma (Phase 2)
Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 2)
Trials (4 total)
Trial APIs (9 total)